Rapid Clinical Updates: Updates on Anticoagulation for Hospitalists

Rounds move faster when anticoagulation calls are crisp. In this case-driven update powered by recent trials and guidelines, compare DOACs vs VKAs after bioprosthetic valve procedures (and apply caution with very early DOAC use), apply CAD/PCI de-escalation strategies and when DOAC alone suffices, prioritize warfarin for antiphospholipid syndrome, navigate ESKD choices with apixaban, time DOAC starts after AF stroke, and avoid routine post-stroke bridging - leaving with step-by-step pathways.

Create Account

Availability

On-Demand

Release on Dec 14, 2026 12:00 AM Central Standard Time
Expires on Dec 13, 2029

Cost

Member: $0.00

Non-Member: $95.00

Credit Offered

1 CME Credit

1 Participation Credit

Faculty
Accreditation

Faculty

Scott Kaatz, DO, MSc, FACP, SFHM
- Dr. Kaatz reports working as a consultant for Bayer, Giliad, Perosphere, Regeneron and doing contracted research for Inari, Perosphere, Regeneron.
Margaret Fang, MD, MPH
Jagriti Chadha, MD, MPH, FACP, SFHM
Ebrahim Barkoudah, MD, MPH, MBA
Joseph Sweigart, MD, SFHM
Lily Ackermann, ScM, MD, FACP, SFHM

Faculty Disclosures
The individuals in control of content for this activity have no relevant relationships with ACCME-defined ineligible companies to disclose unless listed here. Any relevant relationships were mitigated prior to the start of this activity.

Accreditation Statement
The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Statement
The Society of Hospital Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.